Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 124.58% | -21.53% | 1,081.63% | -90.55% | -39.16% |
| Total Depreciation and Amortization | -0.82% | 20.58% | -21.51% | 559.25% | 1.04% |
| Total Amortization of Deferred Charges | -2.63% | -2.56% | 77.27% | -- | -- |
| Total Other Non-Cash Items | -62.55% | 87.88% | -20,485.00% | -81.82% | 110.16% |
| Change in Net Operating Assets | -497.39% | -97.15% | 3,353.23% | -108.77% | 266.84% |
| Cash from Operations | 42.65% | -52.50% | 343.81% | -67.84% | 155.75% |
| Capital Expenditure | 100.00% | 71.43% | 99.99% | -727,354.55% | -83.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 71.43% | 99.99% | -727,354.55% | -83.33% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -19,739.47% | -8.57% | 33.96% | -265.52% | -3.57% |
| Issuance of Common Stock | -67.74% | 106.67% | 50.00% | -58.33% | -76.70% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 87.69% | -- | -- |
| Cash from Financing | -38,146.67% | 56.73% | -100.26% | 790,220.00% | 95.05% |
| Foreign Exchange rate Adjustments | 5,400.00% | 97.83% | -986.54% | 125.24% | -20.47% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -356.09% | -49.92% | 121.61% | -740.68% | 178.43% |